nodes	percent_of_prediction	percent_of_DWPC	metapath
Efavirenz—CYP2C9—Capecitabine—esophageal cancer	0.129	0.407	CbGbCtD
Efavirenz—CYP2B6—Cisplatin—esophageal cancer	0.123	0.388	CbGbCtD
Efavirenz—CYP2C9—Cisplatin—esophageal cancer	0.0648	0.205	CbGbCtD
Efavirenz—Skin discolouration—Methotrexate—esophageal cancer	0.00142	0.00333	CcSEcCtD
Efavirenz—Pancytopenia—Cisplatin—esophageal cancer	0.00139	0.00326	CcSEcCtD
Efavirenz—Hepatic failure—Capecitabine—esophageal cancer	0.00139	0.00326	CcSEcCtD
Efavirenz—Hepatic enzyme increased—Methotrexate—esophageal cancer	0.00135	0.00318	CcSEcCtD
Efavirenz—Ulcer—Methotrexate—esophageal cancer	0.00135	0.00318	CcSEcCtD
Efavirenz—Renal failure acute—Capecitabine—esophageal cancer	0.00135	0.00318	CcSEcCtD
Efavirenz—Hot flush—Capecitabine—esophageal cancer	0.00133	0.00313	CcSEcCtD
Efavirenz—Amnesia—Capecitabine—esophageal cancer	0.00133	0.00312	CcSEcCtD
Efavirenz—Menopausal symptoms—Capecitabine—esophageal cancer	0.00132	0.00311	CcSEcCtD
Efavirenz—Dermatitis exfoliative—Capecitabine—esophageal cancer	0.00132	0.00311	CcSEcCtD
Efavirenz—Inflammation—Methotrexate—esophageal cancer	0.00132	0.0031	CcSEcCtD
Efavirenz—Renal impairment—Capecitabine—esophageal cancer	0.00131	0.00308	CcSEcCtD
Efavirenz—Dermatitis bullous—Capecitabine—esophageal cancer	0.00131	0.00307	CcSEcCtD
Efavirenz—Renal failure—Cisplatin—esophageal cancer	0.00128	0.00301	CcSEcCtD
Efavirenz—Neuropathy peripheral—Cisplatin—esophageal cancer	0.00128	0.003	CcSEcCtD
Efavirenz—Diplopia—Capecitabine—esophageal cancer	0.00125	0.00293	CcSEcCtD
Efavirenz—Depressed level of consciousness—Methotrexate—esophageal cancer	0.00124	0.0029	CcSEcCtD
Efavirenz—Hepatobiliary disease—Cisplatin—esophageal cancer	0.00123	0.0029	CcSEcCtD
Efavirenz—Migraine—Capecitabine—esophageal cancer	0.00123	0.00289	CcSEcCtD
Efavirenz—Skin exfoliation—Methotrexate—esophageal cancer	0.00122	0.00287	CcSEcCtD
Efavirenz—Mood swings—Capecitabine—esophageal cancer	0.00118	0.00278	CcSEcCtD
Efavirenz—Ataxia—Capecitabine—esophageal cancer	0.00117	0.00276	CcSEcCtD
Efavirenz—Blood creatinine increased—Capecitabine—esophageal cancer	0.00117	0.00275	CcSEcCtD
Efavirenz—Urine output increased—Methotrexate—esophageal cancer	0.00116	0.00272	CcSEcCtD
Efavirenz—Urinary tract disorder—Cisplatin—esophageal cancer	0.00116	0.00272	CcSEcCtD
Efavirenz—Connective tissue disorder—Cisplatin—esophageal cancer	0.00115	0.0027	CcSEcCtD
Efavirenz—Urethral disorder—Cisplatin—esophageal cancer	0.00115	0.0027	CcSEcCtD
Efavirenz—Gynaecomastia—Methotrexate—esophageal cancer	0.00115	0.00269	CcSEcCtD
Efavirenz—Hypokalaemia—Capecitabine—esophageal cancer	0.00114	0.00267	CcSEcCtD
Efavirenz—Visual impairment—Cisplatin—esophageal cancer	0.00113	0.00265	CcSEcCtD
Efavirenz—Breast disorder—Capecitabine—esophageal cancer	0.00113	0.00265	CcSEcCtD
Efavirenz—Toxic epidermal necrolysis—Capecitabine—esophageal cancer	0.00112	0.00264	CcSEcCtD
Efavirenz—Nasopharyngitis—Capecitabine—esophageal cancer	0.00112	0.00262	CcSEcCtD
Efavirenz—Muscular weakness—Capecitabine—esophageal cancer	0.0011	0.00259	CcSEcCtD
Efavirenz—Eye disorder—Cisplatin—esophageal cancer	0.00109	0.00257	CcSEcCtD
Efavirenz—Tinnitus—Cisplatin—esophageal cancer	0.00109	0.00257	CcSEcCtD
Efavirenz—Flushing—Cisplatin—esophageal cancer	0.00109	0.00255	CcSEcCtD
Efavirenz—Cardiac disorder—Cisplatin—esophageal cancer	0.00109	0.00255	CcSEcCtD
Efavirenz—Abdominal distension—Capecitabine—esophageal cancer	0.00109	0.00255	CcSEcCtD
Efavirenz—Asthma—Capecitabine—esophageal cancer	0.00108	0.00253	CcSEcCtD
Efavirenz—Thrombophlebitis—Methotrexate—esophageal cancer	0.00107	0.00252	CcSEcCtD
Efavirenz—Polyuria—Methotrexate—esophageal cancer	0.00106	0.00249	CcSEcCtD
Efavirenz—Immune system disorder—Cisplatin—esophageal cancer	0.00106	0.00249	CcSEcCtD
Efavirenz—Mediastinal disorder—Cisplatin—esophageal cancer	0.00106	0.00248	CcSEcCtD
Efavirenz—Sweating increased—Capecitabine—esophageal cancer	0.00105	0.00247	CcSEcCtD
Efavirenz—Arrhythmia—Cisplatin—esophageal cancer	0.00105	0.00246	CcSEcCtD
Efavirenz—Alopecia—Cisplatin—esophageal cancer	0.00104	0.00243	CcSEcCtD
Efavirenz—Hepatic failure—Methotrexate—esophageal cancer	0.00103	0.00243	CcSEcCtD
Efavirenz—Pancytopenia—Capecitabine—esophageal cancer	0.00102	0.00241	CcSEcCtD
Efavirenz—Malnutrition—Cisplatin—esophageal cancer	0.00102	0.00239	CcSEcCtD
Efavirenz—Erythema—Cisplatin—esophageal cancer	0.00102	0.00239	CcSEcCtD
Efavirenz—Renal failure acute—Methotrexate—esophageal cancer	0.00101	0.00236	CcSEcCtD
Efavirenz—Flatulence—Cisplatin—esophageal cancer	0.001	0.00236	CcSEcCtD
Efavirenz—Upper respiratory tract infection—Capecitabine—esophageal cancer	0.001	0.00235	CcSEcCtD
Efavirenz—Dermatitis exfoliative—Methotrexate—esophageal cancer	0.000985	0.00231	CcSEcCtD
Efavirenz—Photosensitivity reaction—Capecitabine—esophageal cancer	0.000985	0.00231	CcSEcCtD
Efavirenz—Hyperglycaemia—Capecitabine—esophageal cancer	0.000973	0.00229	CcSEcCtD
Efavirenz—Pneumonia—Capecitabine—esophageal cancer	0.000967	0.00227	CcSEcCtD
Efavirenz—Infestation NOS—Capecitabine—esophageal cancer	0.000962	0.00226	CcSEcCtD
Efavirenz—Infestation—Capecitabine—esophageal cancer	0.000962	0.00226	CcSEcCtD
Efavirenz—Vision blurred—Cisplatin—esophageal cancer	0.000961	0.00226	CcSEcCtD
Efavirenz—Depression—Capecitabine—esophageal cancer	0.000959	0.00225	CcSEcCtD
Efavirenz—Tremor—Cisplatin—esophageal cancer	0.000955	0.00224	CcSEcCtD
Efavirenz—Stevens-Johnson syndrome—Capecitabine—esophageal cancer	0.000954	0.00224	CcSEcCtD
Efavirenz—Ill-defined disorder—Cisplatin—esophageal cancer	0.000946	0.00222	CcSEcCtD
Efavirenz—Renal failure—Capecitabine—esophageal cancer	0.000945	0.00222	CcSEcCtD
Efavirenz—Neuropathy peripheral—Capecitabine—esophageal cancer	0.000943	0.00221	CcSEcCtD
Efavirenz—Anaemia—Cisplatin—esophageal cancer	0.000942	0.00221	CcSEcCtD
Efavirenz—Jaundice—Capecitabine—esophageal cancer	0.000938	0.0022	CcSEcCtD
Efavirenz—Malaise—Cisplatin—esophageal cancer	0.00092	0.00216	CcSEcCtD
Efavirenz—Haematuria—Capecitabine—esophageal cancer	0.000917	0.00215	CcSEcCtD
Efavirenz—Hepatobiliary disease—Capecitabine—esophageal cancer	0.00091	0.00214	CcSEcCtD
Efavirenz—Convulsion—Cisplatin—esophageal cancer	0.000883	0.00208	CcSEcCtD
Efavirenz—Mood swings—Methotrexate—esophageal cancer	0.00088	0.00207	CcSEcCtD
Efavirenz—Ataxia—Methotrexate—esophageal cancer	0.000874	0.00205	CcSEcCtD
Efavirenz—Myalgia—Cisplatin—esophageal cancer	0.000868	0.00204	CcSEcCtD
Efavirenz—Rhinitis—Capecitabine—esophageal cancer	0.000866	0.00203	CcSEcCtD
Efavirenz—Anxiety—Cisplatin—esophageal cancer	0.000865	0.00203	CcSEcCtD
Efavirenz—Hepatitis—Capecitabine—esophageal cancer	0.000863	0.00203	CcSEcCtD
Efavirenz—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—esophageal cancer	0.000862	0.00202	CcSEcCtD
Efavirenz—Hypoaesthesia—Capecitabine—esophageal cancer	0.000859	0.00202	CcSEcCtD
Efavirenz—Discomfort—Cisplatin—esophageal cancer	0.000858	0.00201	CcSEcCtD
Efavirenz—Urinary tract disorder—Capecitabine—esophageal cancer	0.000853	0.002	CcSEcCtD
Efavirenz—Oedema peripheral—Capecitabine—esophageal cancer	0.000851	0.002	CcSEcCtD
Efavirenz—Connective tissue disorder—Capecitabine—esophageal cancer	0.000848	0.00199	CcSEcCtD
Efavirenz—Urethral disorder—Capecitabine—esophageal cancer	0.000846	0.00199	CcSEcCtD
Efavirenz—Breast disorder—Methotrexate—esophageal cancer	0.00084	0.00197	CcSEcCtD
Efavirenz—Toxic epidermal necrolysis—Methotrexate—esophageal cancer	0.000837	0.00197	CcSEcCtD
Efavirenz—Visual impairment—Capecitabine—esophageal cancer	0.000832	0.00195	CcSEcCtD
Efavirenz—Erythema multiforme—Capecitabine—esophageal cancer	0.000816	0.00192	CcSEcCtD
Efavirenz—Nervous system disorder—Cisplatin—esophageal cancer	0.000816	0.00192	CcSEcCtD
Efavirenz—Thrombocytopenia—Cisplatin—esophageal cancer	0.000815	0.00191	CcSEcCtD
Efavirenz—Tachycardia—Cisplatin—esophageal cancer	0.000812	0.00191	CcSEcCtD
Efavirenz—Skin disorder—Cisplatin—esophageal cancer	0.000808	0.0019	CcSEcCtD
Efavirenz—Eye disorder—Capecitabine—esophageal cancer	0.000807	0.0019	CcSEcCtD
Efavirenz—Tinnitus—Capecitabine—esophageal cancer	0.000805	0.00189	CcSEcCtD
Efavirenz—Hyperhidrosis—Cisplatin—esophageal cancer	0.000804	0.00189	CcSEcCtD
Efavirenz—Asthma—Methotrexate—esophageal cancer	0.000803	0.00189	CcSEcCtD
Efavirenz—Flushing—Capecitabine—esophageal cancer	0.000801	0.00188	CcSEcCtD
Efavirenz—Cardiac disorder—Capecitabine—esophageal cancer	0.000801	0.00188	CcSEcCtD
Efavirenz—Anorexia—Cisplatin—esophageal cancer	0.000793	0.00186	CcSEcCtD
Efavirenz—Pancreatitis—Methotrexate—esophageal cancer	0.000787	0.00185	CcSEcCtD
Efavirenz—Angiopathy—Capecitabine—esophageal cancer	0.000783	0.00184	CcSEcCtD
Efavirenz—Immune system disorder—Capecitabine—esophageal cancer	0.00078	0.00183	CcSEcCtD
Efavirenz—Mediastinal disorder—Capecitabine—esophageal cancer	0.000778	0.00183	CcSEcCtD
Efavirenz—Arrhythmia—Capecitabine—esophageal cancer	0.000771	0.00181	CcSEcCtD
Efavirenz—Alopecia—Capecitabine—esophageal cancer	0.000763	0.00179	CcSEcCtD
Efavirenz—Pancytopenia—Methotrexate—esophageal cancer	0.000763	0.00179	CcSEcCtD
Efavirenz—Musculoskeletal discomfort—Cisplatin—esophageal cancer	0.000758	0.00178	CcSEcCtD
Efavirenz—Erythema—Capecitabine—esophageal cancer	0.000752	0.00177	CcSEcCtD
Efavirenz—Malnutrition—Capecitabine—esophageal cancer	0.000752	0.00177	CcSEcCtD
Efavirenz—Paraesthesia—Cisplatin—esophageal cancer	0.000747	0.00176	CcSEcCtD
Efavirenz—Upper respiratory tract infection—Methotrexate—esophageal cancer	0.000746	0.00175	CcSEcCtD
Efavirenz—Dyspnoea—Cisplatin—esophageal cancer	0.000742	0.00174	CcSEcCtD
Efavirenz—Flatulence—Capecitabine—esophageal cancer	0.000741	0.00174	CcSEcCtD
Efavirenz—Dysgeusia—Capecitabine—esophageal cancer	0.000736	0.00173	CcSEcCtD
Efavirenz—Photosensitivity reaction—Methotrexate—esophageal cancer	0.000733	0.00172	CcSEcCtD
Efavirenz—Back pain—Capecitabine—esophageal cancer	0.000727	0.00171	CcSEcCtD
Efavirenz—Decreased appetite—Cisplatin—esophageal cancer	0.000723	0.0017	CcSEcCtD
Efavirenz—Pneumonia—Methotrexate—esophageal cancer	0.00072	0.00169	CcSEcCtD
Efavirenz—Gastrointestinal disorder—Cisplatin—esophageal cancer	0.000718	0.00169	CcSEcCtD
Efavirenz—Infestation—Methotrexate—esophageal cancer	0.000716	0.00168	CcSEcCtD
Efavirenz—Drowsiness—Methotrexate—esophageal cancer	0.000716	0.00168	CcSEcCtD
Efavirenz—Infestation NOS—Methotrexate—esophageal cancer	0.000716	0.00168	CcSEcCtD
Efavirenz—Depression—Methotrexate—esophageal cancer	0.000714	0.00168	CcSEcCtD
Efavirenz—Pain—Cisplatin—esophageal cancer	0.000712	0.00167	CcSEcCtD
Efavirenz—Stevens-Johnson syndrome—Methotrexate—esophageal cancer	0.00071	0.00167	CcSEcCtD
Efavirenz—Vision blurred—Capecitabine—esophageal cancer	0.000708	0.00166	CcSEcCtD
Efavirenz—Tremor—Capecitabine—esophageal cancer	0.000704	0.00165	CcSEcCtD
Efavirenz—Renal failure—Methotrexate—esophageal cancer	0.000704	0.00165	CcSEcCtD
Efavirenz—Ill-defined disorder—Capecitabine—esophageal cancer	0.000697	0.00164	CcSEcCtD
Efavirenz—Anaemia—Capecitabine—esophageal cancer	0.000695	0.00163	CcSEcCtD
Efavirenz—Sweating—Methotrexate—esophageal cancer	0.000686	0.00161	CcSEcCtD
Efavirenz—Feeling abnormal—Cisplatin—esophageal cancer	0.000686	0.00161	CcSEcCtD
Efavirenz—Haematuria—Methotrexate—esophageal cancer	0.000683	0.0016	CcSEcCtD
Efavirenz—Malaise—Capecitabine—esophageal cancer	0.000678	0.00159	CcSEcCtD
Efavirenz—Hepatobiliary disease—Methotrexate—esophageal cancer	0.000677	0.00159	CcSEcCtD
Efavirenz—Vertigo—Capecitabine—esophageal cancer	0.000675	0.00159	CcSEcCtD
Efavirenz—Syncope—Capecitabine—esophageal cancer	0.000674	0.00158	CcSEcCtD
Efavirenz—Palpitations—Capecitabine—esophageal cancer	0.000664	0.00156	CcSEcCtD
Efavirenz—Loss of consciousness—Capecitabine—esophageal cancer	0.000661	0.00155	CcSEcCtD
Efavirenz—Body temperature increased—Cisplatin—esophageal cancer	0.000658	0.00155	CcSEcCtD
Efavirenz—Cough—Capecitabine—esophageal cancer	0.000656	0.00154	CcSEcCtD
Efavirenz—Hypertension—Capecitabine—esophageal cancer	0.000649	0.00152	CcSEcCtD
Efavirenz—Hepatitis—Methotrexate—esophageal cancer	0.000643	0.00151	CcSEcCtD
Efavirenz—Arthralgia—Capecitabine—esophageal cancer	0.00064	0.0015	CcSEcCtD
Efavirenz—Myalgia—Capecitabine—esophageal cancer	0.00064	0.0015	CcSEcCtD
Efavirenz—Chest pain—Capecitabine—esophageal cancer	0.00064	0.0015	CcSEcCtD
Efavirenz—Anxiety—Capecitabine—esophageal cancer	0.000638	0.0015	CcSEcCtD
Efavirenz—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—esophageal cancer	0.000635	0.00149	CcSEcCtD
Efavirenz—Urinary tract disorder—Methotrexate—esophageal cancer	0.000635	0.00149	CcSEcCtD
Efavirenz—Discomfort—Capecitabine—esophageal cancer	0.000632	0.00149	CcSEcCtD
Efavirenz—Urethral disorder—Methotrexate—esophageal cancer	0.00063	0.00148	CcSEcCtD
Efavirenz—Dry mouth—Capecitabine—esophageal cancer	0.000626	0.00147	CcSEcCtD
Efavirenz—Visual impairment—Methotrexate—esophageal cancer	0.000619	0.00145	CcSEcCtD
Efavirenz—Confusional state—Capecitabine—esophageal cancer	0.000619	0.00145	CcSEcCtD
Efavirenz—Hypersensitivity—Cisplatin—esophageal cancer	0.000613	0.00144	CcSEcCtD
Efavirenz—Erythema multiforme—Methotrexate—esophageal cancer	0.000608	0.00143	CcSEcCtD
Efavirenz—Shock—Capecitabine—esophageal cancer	0.000604	0.00142	CcSEcCtD
Efavirenz—Nervous system disorder—Capecitabine—esophageal cancer	0.000602	0.00141	CcSEcCtD
Efavirenz—Eye disorder—Methotrexate—esophageal cancer	0.000601	0.00141	CcSEcCtD
Efavirenz—Thrombocytopenia—Capecitabine—esophageal cancer	0.000601	0.00141	CcSEcCtD
Efavirenz—Tinnitus—Methotrexate—esophageal cancer	0.000599	0.00141	CcSEcCtD
Efavirenz—Tachycardia—Capecitabine—esophageal cancer	0.000599	0.00141	CcSEcCtD
Efavirenz—Asthenia—Cisplatin—esophageal cancer	0.000597	0.0014	CcSEcCtD
Efavirenz—Cardiac disorder—Methotrexate—esophageal cancer	0.000597	0.0014	CcSEcCtD
Efavirenz—Skin disorder—Capecitabine—esophageal cancer	0.000596	0.0014	CcSEcCtD
Efavirenz—Hyperhidrosis—Capecitabine—esophageal cancer	0.000593	0.00139	CcSEcCtD
Efavirenz—Anorexia—Capecitabine—esophageal cancer	0.000585	0.00137	CcSEcCtD
Efavirenz—Angiopathy—Methotrexate—esophageal cancer	0.000583	0.00137	CcSEcCtD
Efavirenz—Immune system disorder—Methotrexate—esophageal cancer	0.000581	0.00136	CcSEcCtD
Efavirenz—Mediastinal disorder—Methotrexate—esophageal cancer	0.000579	0.00136	CcSEcCtD
Efavirenz—Diarrhoea—Cisplatin—esophageal cancer	0.000569	0.00134	CcSEcCtD
Efavirenz—Alopecia—Methotrexate—esophageal cancer	0.000568	0.00133	CcSEcCtD
Efavirenz—Malnutrition—Methotrexate—esophageal cancer	0.00056	0.00131	CcSEcCtD
Efavirenz—Erythema—Methotrexate—esophageal cancer	0.00056	0.00131	CcSEcCtD
Efavirenz—Musculoskeletal discomfort—Capecitabine—esophageal cancer	0.000559	0.00131	CcSEcCtD
Efavirenz—Insomnia—Capecitabine—esophageal cancer	0.000555	0.0013	CcSEcCtD
Efavirenz—Paraesthesia—Capecitabine—esophageal cancer	0.000551	0.00129	CcSEcCtD
Efavirenz—Dysgeusia—Methotrexate—esophageal cancer	0.000548	0.00129	CcSEcCtD
Efavirenz—Dyspnoea—Capecitabine—esophageal cancer	0.000547	0.00128	CcSEcCtD
Efavirenz—Back pain—Methotrexate—esophageal cancer	0.000541	0.00127	CcSEcCtD
Efavirenz—Dyspepsia—Capecitabine—esophageal cancer	0.00054	0.00127	CcSEcCtD
Efavirenz—Decreased appetite—Capecitabine—esophageal cancer	0.000533	0.00125	CcSEcCtD
Efavirenz—Gastrointestinal disorder—Capecitabine—esophageal cancer	0.00053	0.00124	CcSEcCtD
Efavirenz—Vomiting—Cisplatin—esophageal cancer	0.000529	0.00124	CcSEcCtD
Efavirenz—Fatigue—Capecitabine—esophageal cancer	0.000529	0.00124	CcSEcCtD
Efavirenz—Vision blurred—Methotrexate—esophageal cancer	0.000527	0.00124	CcSEcCtD
Efavirenz—Rash—Cisplatin—esophageal cancer	0.000525	0.00123	CcSEcCtD
Efavirenz—Pain—Capecitabine—esophageal cancer	0.000525	0.00123	CcSEcCtD
Efavirenz—Constipation—Capecitabine—esophageal cancer	0.000525	0.00123	CcSEcCtD
Efavirenz—Dermatitis—Cisplatin—esophageal cancer	0.000524	0.00123	CcSEcCtD
Efavirenz—Ill-defined disorder—Methotrexate—esophageal cancer	0.000519	0.00122	CcSEcCtD
Efavirenz—Anaemia—Methotrexate—esophageal cancer	0.000517	0.00121	CcSEcCtD
Efavirenz—Feeling abnormal—Capecitabine—esophageal cancer	0.000506	0.00119	CcSEcCtD
Efavirenz—Malaise—Methotrexate—esophageal cancer	0.000505	0.00119	CcSEcCtD
Efavirenz—Vertigo—Methotrexate—esophageal cancer	0.000503	0.00118	CcSEcCtD
Efavirenz—Gastrointestinal pain—Capecitabine—esophageal cancer	0.000502	0.00118	CcSEcCtD
Efavirenz—Nausea—Cisplatin—esophageal cancer	0.000494	0.00116	CcSEcCtD
Efavirenz—Cough—Methotrexate—esophageal cancer	0.000488	0.00115	CcSEcCtD
Efavirenz—Urticaria—Capecitabine—esophageal cancer	0.000487	0.00114	CcSEcCtD
Efavirenz—Abdominal pain—Capecitabine—esophageal cancer	0.000485	0.00114	CcSEcCtD
Efavirenz—Body temperature increased—Capecitabine—esophageal cancer	0.000485	0.00114	CcSEcCtD
Efavirenz—Convulsion—Methotrexate—esophageal cancer	0.000485	0.00114	CcSEcCtD
Efavirenz—Arthralgia—Methotrexate—esophageal cancer	0.000476	0.00112	CcSEcCtD
Efavirenz—Myalgia—Methotrexate—esophageal cancer	0.000476	0.00112	CcSEcCtD
Efavirenz—Chest pain—Methotrexate—esophageal cancer	0.000476	0.00112	CcSEcCtD
Efavirenz—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—esophageal cancer	0.000473	0.00111	CcSEcCtD
Efavirenz—Discomfort—Methotrexate—esophageal cancer	0.000471	0.00111	CcSEcCtD
Efavirenz—Confusional state—Methotrexate—esophageal cancer	0.00046	0.00108	CcSEcCtD
Efavirenz—Hypersensitivity—Capecitabine—esophageal cancer	0.000452	0.00106	CcSEcCtD
Efavirenz—Nervous system disorder—Methotrexate—esophageal cancer	0.000448	0.00105	CcSEcCtD
Efavirenz—Thrombocytopenia—Methotrexate—esophageal cancer	0.000447	0.00105	CcSEcCtD
Efavirenz—Skin disorder—Methotrexate—esophageal cancer	0.000444	0.00104	CcSEcCtD
Efavirenz—Hyperhidrosis—Methotrexate—esophageal cancer	0.000441	0.00104	CcSEcCtD
Efavirenz—Asthenia—Capecitabine—esophageal cancer	0.00044	0.00103	CcSEcCtD
Efavirenz—Anorexia—Methotrexate—esophageal cancer	0.000435	0.00102	CcSEcCtD
Efavirenz—Pruritus—Capecitabine—esophageal cancer	0.000434	0.00102	CcSEcCtD
Efavirenz—Diarrhoea—Capecitabine—esophageal cancer	0.00042	0.000986	CcSEcCtD
Efavirenz—Musculoskeletal discomfort—Methotrexate—esophageal cancer	0.000416	0.000977	CcSEcCtD
Efavirenz—Insomnia—Methotrexate—esophageal cancer	0.000413	0.00097	CcSEcCtD
Efavirenz—Paraesthesia—Methotrexate—esophageal cancer	0.00041	0.000963	CcSEcCtD
Efavirenz—Dyspnoea—Methotrexate—esophageal cancer	0.000407	0.000956	CcSEcCtD
Efavirenz—Somnolence—Methotrexate—esophageal cancer	0.000406	0.000954	CcSEcCtD
Efavirenz—Dizziness—Capecitabine—esophageal cancer	0.000406	0.000953	CcSEcCtD
Efavirenz—Dyspepsia—Methotrexate—esophageal cancer	0.000402	0.000944	CcSEcCtD
Efavirenz—Decreased appetite—Methotrexate—esophageal cancer	0.000397	0.000932	CcSEcCtD
Efavirenz—Gastrointestinal disorder—Methotrexate—esophageal cancer	0.000394	0.000926	CcSEcCtD
Efavirenz—Fatigue—Methotrexate—esophageal cancer	0.000394	0.000925	CcSEcCtD
Efavirenz—Pain—Methotrexate—esophageal cancer	0.000391	0.000917	CcSEcCtD
Efavirenz—Vomiting—Capecitabine—esophageal cancer	0.00039	0.000916	CcSEcCtD
Efavirenz—Rash—Capecitabine—esophageal cancer	0.000387	0.000908	CcSEcCtD
Efavirenz—Dermatitis—Capecitabine—esophageal cancer	0.000386	0.000908	CcSEcCtD
Efavirenz—Headache—Capecitabine—esophageal cancer	0.000384	0.000903	CcSEcCtD
Efavirenz—Feeling abnormal—Methotrexate—esophageal cancer	0.000376	0.000884	CcSEcCtD
Efavirenz—Gastrointestinal pain—Methotrexate—esophageal cancer	0.000373	0.000877	CcSEcCtD
Efavirenz—Nausea—Capecitabine—esophageal cancer	0.000364	0.000856	CcSEcCtD
Efavirenz—Urticaria—Methotrexate—esophageal cancer	0.000363	0.000852	CcSEcCtD
Efavirenz—Abdominal pain—Methotrexate—esophageal cancer	0.000361	0.000848	CcSEcCtD
Efavirenz—Body temperature increased—Methotrexate—esophageal cancer	0.000361	0.000848	CcSEcCtD
Efavirenz—Hypersensitivity—Methotrexate—esophageal cancer	0.000336	0.00079	CcSEcCtD
Efavirenz—Asthenia—Methotrexate—esophageal cancer	0.000328	0.00077	CcSEcCtD
Efavirenz—Pruritus—Methotrexate—esophageal cancer	0.000323	0.000759	CcSEcCtD
Efavirenz—Diarrhoea—Methotrexate—esophageal cancer	0.000312	0.000734	CcSEcCtD
Efavirenz—Dizziness—Methotrexate—esophageal cancer	0.000302	0.000709	CcSEcCtD
Efavirenz—Vomiting—Methotrexate—esophageal cancer	0.00029	0.000682	CcSEcCtD
Efavirenz—Rash—Methotrexate—esophageal cancer	0.000288	0.000676	CcSEcCtD
Efavirenz—Dermatitis—Methotrexate—esophageal cancer	0.000288	0.000676	CcSEcCtD
Efavirenz—Headache—Methotrexate—esophageal cancer	0.000286	0.000672	CcSEcCtD
Efavirenz—Nausea—Methotrexate—esophageal cancer	0.000271	0.000637	CcSEcCtD
Efavirenz—CYP2C9—Metapathway biotransformation—CYP1B1—esophageal cancer	0.000218	0.000846	CbGpPWpGaD
Efavirenz—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1A—esophageal cancer	0.000214	0.000829	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism of lipids and lipoproteins—SLC10A2—esophageal cancer	0.000213	0.000827	CbGpPWpGaD
Efavirenz—CYP2D6—Biological oxidations—CYP19A1—esophageal cancer	0.00021	0.000814	CbGpPWpGaD
Efavirenz—CYP2C9—Biological oxidations—CYP19A1—esophageal cancer	0.000208	0.000807	CbGpPWpGaD
Efavirenz—CYP2D6—Metapathway biotransformation—CYP19A1—esophageal cancer	0.000207	0.000802	CbGpPWpGaD
Efavirenz—CYP2C9—Metapathway biotransformation—CYP19A1—esophageal cancer	0.000205	0.000795	CbGpPWpGaD
Efavirenz—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EP300—esophageal cancer	0.000204	0.000789	CbGpPWpGaD
Efavirenz—CYP1A2—Aryl Hydrocarbon Receptor—EP300—esophageal cancer	0.000204	0.000789	CbGpPWpGaD
Efavirenz—CYP3A4—Biological oxidations—ALDH2—esophageal cancer	0.000193	0.000746	CbGpPWpGaD
Efavirenz—CYP1A2—Biological oxidations—CYP1B1—esophageal cancer	0.000189	0.000733	CbGpPWpGaD
Efavirenz—CYP1A2—Metapathway biotransformation—CYP1B1—esophageal cancer	0.000186	0.000723	CbGpPWpGaD
Efavirenz—CYP3A4—Biological oxidations—GSTT1—esophageal cancer	0.000183	0.00071	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism of lipids and lipoproteins—SLC10A2—esophageal cancer	0.000182	0.000707	CbGpPWpGaD
Efavirenz—CYP3A4—Biological oxidations—CYP2A6—esophageal cancer	0.000181	0.000702	CbGpPWpGaD
Efavirenz—CYP1A2—Biological oxidations—CYP19A1—esophageal cancer	0.000178	0.000689	CbGpPWpGaD
Efavirenz—CYP1A2—Aryl Hydrocarbon Receptor—MYC—esophageal cancer	0.000177	0.000688	CbGpPWpGaD
Efavirenz—CYP1A2—Metapathway biotransformation—CYP19A1—esophageal cancer	0.000175	0.00068	CbGpPWpGaD
Efavirenz—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—esophageal cancer	0.000174	0.000673	CbGpPWpGaD
Efavirenz—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—esophageal cancer	0.000174	0.000673	CbGpPWpGaD
Efavirenz—CYP3A4—Biological oxidations—PTGS1—esophageal cancer	0.000172	0.000665	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—SLC52A3—esophageal cancer	0.000162	0.000629	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—BLVRB—esophageal cancer	0.000162	0.000629	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism of lipids and lipoproteins—ALOX15—esophageal cancer	0.000158	0.000613	CbGpPWpGaD
Efavirenz—CYP3A4—Biological oxidations—CYP1B1—esophageal cancer	0.000146	0.000566	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism of lipids and lipoproteins—ALOX15—esophageal cancer	0.000144	0.000559	CbGpPWpGaD
Efavirenz—CYP3A4—Metapathway biotransformation—CYP1B1—esophageal cancer	0.000144	0.000558	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism of lipids and lipoproteins—CRABP1—esophageal cancer	0.000138	0.000535	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—SLC10A2—esophageal cancer	0.000138	0.000535	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—CA1—esophageal cancer	0.000138	0.000535	CbGpPWpGaD
Efavirenz—CYP3A4—Biological oxidations—CYP19A1—esophageal cancer	0.000137	0.000532	CbGpPWpGaD
Efavirenz—CYP3A4—Metapathway biotransformation—CYP19A1—esophageal cancer	0.000135	0.000525	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—CA2—esophageal cancer	0.000126	0.000489	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism of lipids and lipoproteins—CRABP1—esophageal cancer	0.000126	0.000488	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism of lipids and lipoproteins—ALOX15—esophageal cancer	0.000123	0.000478	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—BLVRB—esophageal cancer	0.000123	0.000475	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—SLC52A3—esophageal cancer	0.000123	0.000475	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—ADH7—esophageal cancer	0.000117	0.000455	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—PLCE1—esophageal cancer	0.000117	0.000455	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—BLVRB—esophageal cancer	0.000113	0.000437	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—SLC52A3—esophageal cancer	0.000113	0.000437	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—BLVRB—esophageal cancer	0.000112	0.000433	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—SLC52A3—esophageal cancer	0.000112	0.000433	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism of lipids and lipoproteins—PTGS1—esophageal cancer	0.00011	0.000425	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism of lipids and lipoproteins—CRABP1—esophageal cancer	0.000107	0.000417	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—SLC10A2—esophageal cancer	0.000104	0.000404	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—CA1—esophageal cancer	0.000104	0.000404	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—ADH1B—esophageal cancer	0.000103	0.000399	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism of lipids and lipoproteins—PTGS1—esophageal cancer	9.99e-05	0.000387	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—TYMP—esophageal cancer	9.83e-05	0.000381	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—CA1—esophageal cancer	9.59e-05	0.000372	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—SLC10A2—esophageal cancer	9.59e-05	0.000372	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—CYP26A1—esophageal cancer	9.56e-05	0.000371	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—BLVRB—esophageal cancer	9.55e-05	0.00037	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—SLC52A3—esophageal cancer	9.55e-05	0.00037	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—CA2—esophageal cancer	9.53e-05	0.00037	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—SLC10A2—esophageal cancer	9.51e-05	0.000368	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—CA1—esophageal cancer	9.51e-05	0.000368	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism of lipids and lipoproteins—CYP1B1—esophageal cancer	9.32e-05	0.000361	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—ALOX15—esophageal cancer	9.32e-05	0.000361	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—GSTO1—esophageal cancer	8.89e-05	0.000345	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—TPI1—esophageal cancer	8.89e-05	0.000345	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—PLCE1—esophageal cancer	8.86e-05	0.000344	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—ADH7—esophageal cancer	8.86e-05	0.000344	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—CA2—esophageal cancer	8.77e-05	0.00034	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism of lipids and lipoproteins—CYP19A1—esophageal cancer	8.76e-05	0.00034	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—CA2—esophageal cancer	8.69e-05	0.000337	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism of lipids and lipoproteins—PTGS1—esophageal cancer	8.54e-05	0.000331	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—ALDOB—esophageal cancer	8.52e-05	0.00033	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism of lipids and lipoproteins—CYP1B1—esophageal cancer	8.5e-05	0.000329	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—GAPDH—esophageal cancer	8.2e-05	0.000318	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—PLCE1—esophageal cancer	8.15e-05	0.000316	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—ADH7—esophageal cancer	8.15e-05	0.000316	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—CRABP1—esophageal cancer	8.13e-05	0.000315	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—CA1—esophageal cancer	8.12e-05	0.000315	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—SLC10A2—esophageal cancer	8.12e-05	0.000315	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—ADH7—esophageal cancer	8.08e-05	0.000313	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—PLCE1—esophageal cancer	8.08e-05	0.000313	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—esophageal cancer	7.99e-05	0.00031	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—ADH1B—esophageal cancer	7.77e-05	0.000301	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—GNG7—esophageal cancer	7.73e-05	0.0003	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—CA2—esophageal cancer	7.43e-05	0.000288	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—TYMP—esophageal cancer	7.43e-05	0.000288	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—BLVRB—esophageal cancer	7.37e-05	0.000286	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—SLC52A3—esophageal cancer	7.37e-05	0.000286	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism of lipids and lipoproteins—CYP1B1—esophageal cancer	7.26e-05	0.000281	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—ALDH2—esophageal cancer	7.25e-05	0.000281	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—CYP26A1—esophageal cancer	7.23e-05	0.00028	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—ADH1B—esophageal cancer	7.15e-05	0.000277	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—ADH1B—esophageal cancer	7.09e-05	0.000275	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—ALOX15—esophageal cancer	7.04e-05	0.000273	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—PLCE1—esophageal cancer	6.91e-05	0.000268	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—ADH7—esophageal cancer	6.91e-05	0.000268	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—GSTT1—esophageal cancer	6.89e-05	0.000267	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—TYMP—esophageal cancer	6.83e-05	0.000265	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism of lipids and lipoproteins—CYP19A1—esophageal cancer	6.83e-05	0.000265	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—CYP2A6—esophageal cancer	6.81e-05	0.000264	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—TYMP—esophageal cancer	6.77e-05	0.000263	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—TPI1—esophageal cancer	6.72e-05	0.00026	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—GSTO1—esophageal cancer	6.72e-05	0.00026	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—CYP26A1—esophageal cancer	6.65e-05	0.000258	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—CYP26A1—esophageal cancer	6.59e-05	0.000255	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—ALOX15—esophageal cancer	6.48e-05	0.000251	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—PTGS1—esophageal cancer	6.46e-05	0.00025	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—ENO1—esophageal cancer	6.46e-05	0.00025	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—ALDOB—esophageal cancer	6.44e-05	0.00025	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—ALOX15—esophageal cancer	6.42e-05	0.000249	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—PSME2—esophageal cancer	6.36e-05	0.000247	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—PSME1—esophageal cancer	6.36e-05	0.000247	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—CA1—esophageal cancer	6.27e-05	0.000243	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—SLC10A2—esophageal cancer	6.27e-05	0.000243	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—GAPDH—esophageal cancer	6.2e-05	0.00024	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—TPI1—esophageal cancer	6.18e-05	0.00024	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—GSTO1—esophageal cancer	6.18e-05	0.00024	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—CRABP1—esophageal cancer	6.14e-05	0.000238	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—TPI1—esophageal cancer	6.13e-05	0.000237	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—GSTO1—esophageal cancer	6.13e-05	0.000237	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—ADH1B—esophageal cancer	6.06e-05	0.000235	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—ALDOB—esophageal cancer	5.92e-05	0.00023	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—ALDOB—esophageal cancer	5.87e-05	0.000228	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—GNG7—esophageal cancer	5.84e-05	0.000227	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—TYMP—esophageal cancer	5.79e-05	0.000224	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—CA2—esophageal cancer	5.73e-05	0.000222	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—GAPDH—esophageal cancer	5.7e-05	0.000221	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—GAPDH—esophageal cancer	5.65e-05	0.000219	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—CRABP1—esophageal cancer	5.65e-05	0.000219	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—CYP26A1—esophageal cancer	5.63e-05	0.000218	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—CRABP1—esophageal cancer	5.6e-05	0.000217	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—CYP1B1—esophageal cancer	5.49e-05	0.000213	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—ALOX15—esophageal cancer	5.49e-05	0.000213	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—ALDH2—esophageal cancer	5.48e-05	0.000212	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—GNG7—esophageal cancer	5.38e-05	0.000208	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—PLCE1—esophageal cancer	5.33e-05	0.000207	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—ADH7—esophageal cancer	5.33e-05	0.000207	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—GNG7—esophageal cancer	5.33e-05	0.000207	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—GSTO1—esophageal cancer	5.23e-05	0.000203	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—TPI1—esophageal cancer	5.23e-05	0.000203	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—GSTT1—esophageal cancer	5.21e-05	0.000202	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—CYP19A1—esophageal cancer	5.16e-05	0.0002	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—CYP2A6—esophageal cancer	5.15e-05	0.0002	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	5.13e-05	0.000199	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—ALDH2—esophageal cancer	5.04e-05	0.000195	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—ALDOB—esophageal cancer	5.02e-05	0.000195	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—ALDH2—esophageal cancer	4.99e-05	0.000194	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—ENO1—esophageal cancer	4.88e-05	0.000189	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—PTGS1—esophageal cancer	4.88e-05	0.000189	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—GAPDH—esophageal cancer	4.83e-05	0.000187	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—PSME2—esophageal cancer	4.81e-05	0.000186	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—PSME1—esophageal cancer	4.81e-05	0.000186	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—GSTT1—esophageal cancer	4.79e-05	0.000186	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—CRABP1—esophageal cancer	4.79e-05	0.000186	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—GSTT1—esophageal cancer	4.75e-05	0.000184	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—CYP2A6—esophageal cancer	4.74e-05	0.000184	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—HMOX1—esophageal cancer	4.71e-05	0.000183	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—CYP2A6—esophageal cancer	4.69e-05	0.000182	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	4.68e-05	0.000181	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—ADH1B—esophageal cancer	4.67e-05	0.000181	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—GNG7—esophageal cancer	4.55e-05	0.000177	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—ABCB1—esophageal cancer	4.52e-05	0.000175	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—PTGS1—esophageal cancer	4.49e-05	0.000174	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—ENO1—esophageal cancer	4.49e-05	0.000174	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—TYMP—esophageal cancer	4.47e-05	0.000173	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—ENO1—esophageal cancer	4.45e-05	0.000173	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—PTGS1—esophageal cancer	4.45e-05	0.000173	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—PSME2—esophageal cancer	4.42e-05	0.000171	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—PSME1—esophageal cancer	4.42e-05	0.000171	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—PSME2—esophageal cancer	4.39e-05	0.00017	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—PSME1—esophageal cancer	4.39e-05	0.00017	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—CYP26A1—esophageal cancer	4.35e-05	0.000168	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—ALDH2—esophageal cancer	4.27e-05	0.000165	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—ALOX15—esophageal cancer	4.23e-05	0.000164	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	4.2e-05	0.000163	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—CYP1B1—esophageal cancer	4.15e-05	0.000161	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—GSTT1—esophageal cancer	4.06e-05	0.000157	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—TPI1—esophageal cancer	4.04e-05	0.000157	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—GSTO1—esophageal cancer	4.04e-05	0.000157	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—CYP2A6—esophageal cancer	4.01e-05	0.000156	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	4e-05	0.000155	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—CYP19A1—esophageal cancer	3.9e-05	0.000151	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—ALDOB—esophageal cancer	3.87e-05	0.00015	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	3.83e-05	0.000148	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—CYP1B1—esophageal cancer	3.82e-05	0.000148	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—PTGS1—esophageal cancer	3.8e-05	0.000147	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—ENO1—esophageal cancer	3.8e-05	0.000147	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—CYP1B1—esophageal cancer	3.78e-05	0.000147	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—PSME1—esophageal cancer	3.75e-05	0.000145	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—PSME2—esophageal cancer	3.75e-05	0.000145	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—GAPDH—esophageal cancer	3.73e-05	0.000145	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—CRABP1—esophageal cancer	3.69e-05	0.000143	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—CYP19A1—esophageal cancer	3.59e-05	0.000139	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—HMOX1—esophageal cancer	3.56e-05	0.000138	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—CYP19A1—esophageal cancer	3.56e-05	0.000138	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—GNG7—esophageal cancer	3.51e-05	0.000136	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	3.49e-05	0.000135	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—ABCB1—esophageal cancer	3.42e-05	0.000132	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—ALDH2—esophageal cancer	3.29e-05	0.000128	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—HMOX1—esophageal cancer	3.28e-05	0.000127	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	3.27e-05	0.000127	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—HMOX1—esophageal cancer	3.25e-05	0.000126	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—CYP1B1—esophageal cancer	3.23e-05	0.000125	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	3.19e-05	0.000123	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—ABCB1—esophageal cancer	3.14e-05	0.000122	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—GSTT1—esophageal cancer	3.13e-05	0.000121	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—ABCB1—esophageal cancer	3.12e-05	0.000121	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—CYP2A6—esophageal cancer	3.1e-05	0.00012	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—CYP19A1—esophageal cancer	3.04e-05	0.000118	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—CREBBP—esophageal cancer	3.02e-05	0.000117	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—PTGS1—esophageal cancer	2.94e-05	0.000114	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—ENO1—esophageal cancer	2.94e-05	0.000114	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—PSME2—esophageal cancer	2.89e-05	0.000112	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—PSME1—esophageal cancer	2.89e-05	0.000112	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—HMOX1—esophageal cancer	2.77e-05	0.000108	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	2.72e-05	0.000106	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—NOS3—esophageal cancer	2.71e-05	0.000105	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—ABCB1—esophageal cancer	2.66e-05	0.000103	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	2.58e-05	0.0001	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—CYP1B1—esophageal cancer	2.5e-05	9.67e-05	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—PTGS2—esophageal cancer	2.48e-05	9.6e-05	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	2.36e-05	9.13e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—CYP19A1—esophageal cancer	2.35e-05	9.1e-05	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—CREBBP—esophageal cancer	2.28e-05	8.85e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—HMOX1—esophageal cancer	2.14e-05	8.3e-05	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—CREBBP—esophageal cancer	2.1e-05	8.14e-05	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—CREBBP—esophageal cancer	2.08e-05	8.07e-05	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—EP300—esophageal cancer	2.06e-05	7.98e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—ABCB1—esophageal cancer	2.06e-05	7.97e-05	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—NOS3—esophageal cancer	2.05e-05	7.93e-05	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	2.01e-05	7.81e-05	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—NOS3—esophageal cancer	1.88e-05	7.29e-05	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—PTGS2—esophageal cancer	1.87e-05	7.25e-05	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—NOS3—esophageal cancer	1.86e-05	7.23e-05	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—CREBBP—esophageal cancer	1.78e-05	6.9e-05	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—PTGS2—esophageal cancer	1.72e-05	6.67e-05	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—PTGS2—esophageal cancer	1.71e-05	6.61e-05	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—NOS3—esophageal cancer	1.59e-05	6.18e-05	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—EP300—esophageal cancer	1.56e-05	6.03e-05	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—PIK3CA—esophageal cancer	1.52e-05	5.9e-05	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—PTGS2—esophageal cancer	1.46e-05	5.65e-05	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—EP300—esophageal cancer	1.43e-05	5.55e-05	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—EP300—esophageal cancer	1.42e-05	5.5e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—CREBBP—esophageal cancer	1.37e-05	5.32e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—NOS3—esophageal cancer	1.23e-05	4.77e-05	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—EP300—esophageal cancer	1.21e-05	4.7e-05	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—PIK3CA—esophageal cancer	1.15e-05	4.46e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—PTGS2—esophageal cancer	1.12e-05	4.36e-05	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—PIK3CA—esophageal cancer	1.06e-05	4.1e-05	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—PIK3CA—esophageal cancer	1.05e-05	4.07e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—EP300—esophageal cancer	9.36e-06	3.63e-05	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—PIK3CA—esophageal cancer	8.97e-06	3.48e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—PIK3CA—esophageal cancer	6.92e-06	2.68e-05	CbGpPWpGaD
